Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Vociprotafib | 2172652-48-9 | 99.7% | C20H27ClN6O2S | 50 MG
SDP

Supplier:  Medchemexpress LLC HY14152350MG

Encompass_Preferred

Vociprotafib is an orally active, selective, and potent phosphatase SHP2 inhibitor. It blocks the activation of the RAS-RAF-MEK-ERK signaling pathway, demonstrating antitumor activity. It has been shown to accelerate tumor regressions in Osimertinib-sensitive EGFR-mutant tumors in mice and delays or reduces tumor regrowth upon cessation of treatment.

  • Selective and potent SHP2 inhibitor
  • Blocks RAS-RAF-MEK-ERK signaling pathway activation
  • Accelerates tumor regressions in Osimertinib-sensitive EGFR-mutant tumors
  • Delays and/or reduces tumor regrowth
  • Effective in PDX models with resistance to Osimertinib via c-MET amplification

Catalog No. 50-003-55122


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.